TP53 and pheochromocytoma: The kit did not include genes that have been shown to be involved in the pathogenesis of paragangliomas and pheochromocytomas, except TP53, BRCA1, and BRCA2. A panel of genes accurately reflecting the ML in CBT is also unknown.